<div class="entities" style="line-height: 2.5; direction: ltr"> “To minimize the likelihood of a new surge of COVID-19 cases, WHO continues to advocate for a risk-based approach as non-pharmaceutical interventions are adjusted and calibrated with the decreasing transmission,” said WHO Representative to the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Philippines
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 Dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Rabindra Abeyasinghe
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
.</div>